Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sana Biotechnology, Inc.

2.81
-0.0600-2.09%
Post-market: 2.820.0100+0.36%19:43 EDT
Volume:5.97M
Turnover:16.89M
Market Cap:633.81M
PE:-3.18
High:2.90
Open:2.90
Low:2.79
Close:2.87
Loading ...

Sana Biotechnology upgraded to Buy from Hold at TD Cowen

TIPRANKS
·
08 Jan

Citi Keeps Their Buy Rating on Sana Biotechnology (SANA)

TIPRANKS
·
08 Jan

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sana Biotechnology (SANA), Immuneering (IMRX) and Johnson & Johnson (JNJ)

TIPRANKS
·
08 Jan

Sana Biotechnology’s Promising UP421 Results and Potential Upside: A Buy Rating Affirmed

TIPRANKS
·
08 Jan

Sana Biotechnology Inc : TD Cowen Raises to Buy From Hold

THOMSON REUTERS
·
08 Jan

Sana Biotech Shares up 245% Premarket After Positive Early Results From Type 1 Diabetes Study

THOMSON REUTERS
·
08 Jan

24H | Nvidia Rebounds 1%; Quantum Computing Stock Tumbles 14%; Sana Biotech Rallies 327%

Tiger Newspress
·
08 Jan

Stocks to Watch: Sana Biotechnology, Richardson Electronics, Maplebear

Dow Jones
·
08 Jan

Sana Biotechnology Shares Almost Triple in After Hours Trading Following 'Positive' Diabetes Study Results

MT Newswires Live
·
08 Jan

Sana Biotechnology Shares Spike Following Successful Transplantation

Dow Jones
·
08 Jan

BRIEF-Sana Biotechnology Announces Positive Clinical Results From Type 1 Diabetes Study Of Islet Cell Transplantation Without Immunosuppression

Reuters
·
08 Jan

Sana Biotechnology up 285% afterhours following type 1 diabetes study data

TIPRANKS
·
08 Jan

Sana Biotechnology Reports 'Positive' Results From Diabetes Study of Islet Cell Transplantation; Shares Surge

MT Newswires Live
·
08 Jan

Sana Biotechnology announces initial results from type 1 diabetes study

TIPRANKS
·
08 Jan

Sana Biotechnology Inc -Mri Shows Signals Consistent With Graft Survival 28 Days After Transplantation

THOMSON REUTERS
·
08 Jan

Sana Biotechnology Announces Positive Clinical Results From Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

THOMSON REUTERS
·
08 Jan

Sana Biotechnology Inc - Study Identifies No Safety Issues, Hip-Modified Islet Cells Evade Immune Responses

THOMSON REUTERS
·
08 Jan

Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

GlobeNewswire
·
08 Jan

BofA Securities Adjusts Price Target on Sana Biotechnology to $7 From $8, Maintains Buy Rating

MT Newswires Live
·
08 Jan

Sana Biotechnology Inc : Bofa Global Research Cuts Price Objective to $7 From $8

THOMSON REUTERS
·
07 Jan